Cabot Corporation $CBT Shares Sold by Algert Global LLC

Key Points

• Algert Global LLC reduced its holdings in Cabot Corporation by 49.4%, owning $3.53 million worth of shares after selling 41,470 shares in the first quarter.
• CEO Sean D. Keohane sold 114,436 shares at an average price of $79.28, reflecting a 24.04% decrease in his position, leaving him with approximately $28.66 million in shares.
• The company recently reported a net margin of 11.14% and declared a quarterly dividend of $0.45 per share, contributing to an annualized yield of 2.3%.

Algert Global LLC reduced its position in Cabot Corporation (NYSE:CBT - Free Report) by 49.4% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 42,494 shares of the specialty chemicals company's stock after selling 41,470 shares during the quarter. Algert Global LLC owned about 0.08% of Cabot worth $3,533,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. Beverly Hills Private Wealth LLC increased its stake in Cabot by 3.6% in the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company's stock valued at $326,000 after buying an additional 135 shares during the period. Isthmus Partners LLC increased its stake in Cabot by 4.6% in the 1st quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company's stock valued at $354,000 after buying an additional 186 shares during the period. CWM LLC increased its stake in Cabot by 55.0% in the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock valued at $50,000 after buying an additional 213 shares during the period. GAMMA Investing LLC increased its stake in Cabot by 26.1% in the 1st quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company's stock valued at $141,000 after buying an additional 352 shares during the period. Finally, Captrust Financial Advisors increased its stake in Cabot by 4.4% in the 4th quarter. Captrust Financial Advisors now owns 9,489 shares of the specialty chemicals company's stock valued at $866,000 after buying an additional 399 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Cabot

In other news, CEO Sean D. Keohane sold 114,436 shares of the company's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the completion of the transaction, the chief executive officer owned 361,518 shares of the company's stock, valued at $28,661,147.04. This represents a 24.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 3.03% of the stock is currently owned by corporate insiders.

Cabot Price Performance

Shares of Cabot stock traded down $1.3440 on Monday, hitting $81.5960. The company's stock had a trading volume of 215,073 shares, compared to its average volume of 434,107. Cabot Corporation has a 52-week low of $70.40 and a 52-week high of $117.46. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The firm has a fifty day moving average price of $76.83 and a 200-day moving average price of $78.77. The company has a market capitalization of $4.34 billion, a P/E ratio of 10.67 and a beta of 0.87.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The specialty chemicals company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.80 by $0.10. The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, equities research analysts expect that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Friday, August 29th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.2%. Cabot's dividend payout ratio is currently 23.53%.

Analyst Ratings Changes

Several equities analysts have issued reports on CBT shares. UBS Group set a $82.00 price objective on shares of Cabot and gave the company a "neutral" rating in a research note on Tuesday, August 5th. Wall Street Zen lowered shares of Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $92.33.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.